<DOC>
	<DOCNO>NCT01548157</DOCNO>
	<brief_summary>The purpose study evaluate pharmacokinetics safety oral administration HCP1007 capsule Rosuvastatin plus Omega-3 .</brief_summary>
	<brief_title>Clinical Trial Evaluate Effect Pharmacokinetic Characteristics HCP1007 Capsule</brief_title>
	<detailed_description>The purpose study evaluate pharmacokinetics safety oral administration HCP1007 capsule Rosuvastatin plus Omega-3 .</detailed_description>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Healthy male volunteer , age 20 45 Informed investigational nature study voluntarily agree participate study BMI ＞20kg/m2 ＜26kg/m2 subject Use prescription medication within 14 day prior Day 1 Use medication within 7 day prior Day 1 Participation another clinical study within 60 day prior start study drug administration</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>HCP1007</keyword>
	<keyword>Rosuvastatin</keyword>
	<keyword>Omega-3</keyword>
</DOC>